Medical Economics January 5, 2024
Internal medicine physicians ‘concerned’ about patients ordering prescription drugs directly from pharmaceutical makers.
Pharmaceutical maker Eli Lilly and Company has launched a program to make its medicines directly available to patients with diabetes, migraine and obesity.
The drug manufacturer based in Indianapolis, Indiana, announced on Jan. 4 announced its new LillyDirect “digital health care experience,” with online access to independent health care providers. Patients can receive prescribed medications via direct home delivery, and NBC News reported the program was the first of its kind by a pharmaceutical company.
“A complex U.S. health care system adds to the burdens patients face when managing a chronic disease,” company Chair and CEO David A. Ricks said in a news release. “With LillyDirect, our...
Today's Sponsors
Today's Sponsor